Replies to post #183028 on Biotech Values

[DewDiligence]

I now value EDP-239 at zero, which reduces the bottom-line figure by about $5/sh.

[DewDiligence]

…reasonable people can disagree.

Absolutely; however, using your own model assumptions, I don’t see how your bottom-line figure can possibly lead to the conclusion that ENTA is fully-valued at the current share price (as you posted in #msg-107376372).